GSK seeks approval for world's first malaria vaccine.
D000276:Adjuvants, Immunologic / Q000008:administration & dosage / Q000009:adverse effects; D017277:Drug Approval; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008288:Malaria / Q000517:prevention & control*; D017780:Malaria Vaccines / Q000009:adverse effects / Q000276:immunology* / Q000302:isolation & purification*
D000276:Adjuvants, Immunologic; D017780:Malaria Vaccines